Aktionärsstruktur

Inhaber in %
Freefloat 98,52
Artisan Partners LP 4,73
Vanguard International Growth Fund 3,97
Vanguard Health Care Fund 2,88
Government Pension Fund - Global (The) 1,69
EdgePoint Global Portfolio 1,63
Vanguard Total International Stock Index Fund 1,38
Goldman Sachs GQG Partners International Opportunities Fund 1,24
Artisan International Fund 1,20
Jan G. J. van de Winkel, PhD 1,03
EdgePoint Global Growth & Income Portfolio 1,01
Artisan Mid Cap Fund 0,82
American Funds EuroPacific Growth Fund 0,70
Artisan Global Opportunities Fund 0,62
Stichting Pensioenfonds ABP (Global Equity Portfolio) 0,61

*Die Summe der Anteile kann 100% überschreiten, da bestimmte Anteilseigner zum Freefloat dazu gerechnet wurden.

Personal

2015 2016 2017 2018 2019
Personal am Ende des Jahres 186 205 257 377 548
Umsatz pro Mitarbeiter in Mio. EUR 6,09 8,86 9,20 8,02 9,79

Bilanz (in Mio. EUR) - Aktiva

2015 2016 2017 2018 2019
Summe Umlaufvermögen 3.668 4.898 6.059 7.433 13.961
Summe Anlagevermögen 3.487 4.827 6.272 8.014 14.229
Summe Aktiva 3.903 5.238 6.603 8.461 15.144

Bilanz (in Mio. EUR) - Passiva

2015 2016 2017 2018 2019
Gesamtverschuldung/ -verbindlichkeiten 0 0 0 0 181
Summe Fremdkapital 416 412 331 447 1.096
Summe Eigenkapital 3.487 4.827 6.272 8.014 14.048
Summe Passiva 3.903 5.238 6.603 8.461 15.144

Adresse

Kalvebod Brygge 43, 1560 Copenhagen
Internet http://www.genmab.com

Management

Anders Gersel Pedersen
Non-Independent Director
Anthony Mancini
Chief Operating Officer & Executive Vice President
Anthony Pagano
Chief Financial Officer & Executive Vice President
Birgitte Stephensen
Senior VP-Intellectual Property Rights & Legal
Daniel John Bruno
Vice President-Controller
Deirdre P. Connelly
Chairman
Jan G. J. van de Winkel
President & Chief Executive Officer
Jonathan M. Peacock
Independent Director
Judith Klimovsky
Chief Development Officer & Executive VP
Marisol Peron
Vice President-Investor Relations & Communications
Martine J. van Vugt
Chief of Staff & Senior Vice President
Michael K. Bauer
SVP, Head-Operations, Research & Development
Mijke Zachariasse
Non-Independent Director
Paolo Augusto Paoletti
Independent Director
Pernille Lyngvold Erenbjerg
Deputy Chairman
Peter Storm Kristensen
Non-Independent Director
Rima Bawarsh Nassar
Non-Independent Director
Rolf K. Hoffmann
Independent Director
Tahamtan Ahmadi
Senior Vice President & Head-Oncology